177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

NCT07145177 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Prostate Cancer

Interventions

DRUG: 177Lu-PSMA-617
PROCEDURE: Ablation
PROCEDURE: Trans-arterial chemoembolization (TACE)
PROCEDURE: Positron Emission Tomography (PET)/Computerized tomography (CT)
PROCEDURE: Tumor Biopsy
OTHER: Questionnaire

Sponsor

University of California, San Francisco

Collaborators

[object Object]